3 Recruiting Hypereosinophilic Syndrome Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Hypereosinophilic Syndrome Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
📍 Research Site — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
📍 GSK Investigational Site — San Diego, California
View Study & Checklist ➔